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Baculovirus gp64 envelope glycoprotein is a major component of the envelope of the budded virus and is involved in virus
entry into the host cells by endocytosis. To investigate the cell-surface molecules important for infection of baculovirus into
mammalian cells, we constructed a recombinant baculovirus, Ac64-CAluc, which has gp64 and luciferase genes under the
polyhedrin and the CAG promoter, respectively. For controls, we constructed recombinant viruses possessing vesicular
stomatitis virus (VSV) G protein, mouse hepatitis virus (MHV) S protein, or green fluorescent protein (GFP) gene under the
polyhedrin promoter and the luciferase gene under the CAG promoter (AcVSVG-CAluc, AcMHVS-CAluc, and AcGFP-CAluc).
Treatment of HepG2 cells with phospholipase C markedly reduced the reporter gene expression by Ac64-CAluc or
AcVSVG-CAluc in a dose-dependent manner, whereas AcMHVS-CAluc was shown to be resistant to the treatment. Inhibition
with purified lipids and susceptibility to the mutant CHO hamster cell lines deficient in phospholipids synthesis suggest that
the interaction of gp64 and phospholipids on the cell surface might play an important role in baculovirus infection into
mammalian cells. © 2001 Academic Press
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Many viral vectors have been developed for gene
transfer in vitro, ex vivo, and in vivo. Retroviruses, adeno-
viruses, and adeno-associated viruses are currently
used for gene delivery into mammalian hosts to test their
application for gene therapy both in vitro and in vivo
Mulligan, 1993). These viral vectors are attractive be-
ause of their natural adaptation to mammalian hosts.
owever, their practical use may also raise serious con-
erns, for example, the emergence of replication-compe-
ent viruses, cytotoxicity, preexisting immune responses,
nd undesired viral gene expression.
The baculovirus Autographa californica nuclear poly-
edrosis virus (AcNPV) expression system has been
sed for the expression of various foreign genes be-
ause of its high-level expression in insect cells. Its host
pecificity was originally thought to be restricted to cells
erived from arthropods; however, it has been shown
hat AcNPV can infect mammalian cell lines (Hofmann et
al., 1995; Boyce and Bucher, 1996), including hepatocytes
and nonhepatocytes (Shoji et al., 1997), and stably main-
ain the expression cassette of the viral genome in the
ammalian cells (Condreay et al., 1999). The advantages
f the baculovirus vector are (i) a large capacity for the
nsertion of foreign DNAs, (ii) easy generation of recom-o
T
1 To whom reprint requests should be addressed. Fax: 81-6-6879-
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343inant viruses, and (iii) absence of the preexisting anti-
odies against baculovirus in animals. Recently, exten-
ion of the host range of the baculovirus and enhance-
ent of foreign gene expression were further
emonstrated by constructing a pseudotype virus pos-
essing the vesicular stomatitis virus G glycoprotein
VSV-G) (Barsoum et al., 1997) and by using histone
eacetylase inhibitor, which increased the transcription
evel (Condreay et al., 1999).
In general, viruses initiate infection in target cells by
nteracting with specific receptors on the cell surface.
hose receptors are major determinants of viral tropism
n tissues and species. Enveloped viruses recognize the
pecific receptors by their proteins, which are embedded
n the viral outer membrane. Baculovirus that buds from
he cell surface preferentially incorporates an envelope
usion glycoprotein, gp64, which is necessary for entry
nto host cells. Although recent studies revealed that
aculovirus vectors, including pseudotype recombinants,
fficiently infected mammalian cells and expressed for-
ign genes, the mode of entry of the baculovirus into the
arget mammalian cells remains unknown.
In this study, we have constructed a recombinant bac-
lovirus that increases the concentration of gp64 on the
irion surface. This recombinant baculovirus was capa-
le of efficient transduction in many mammalian cells.
nalyses of infection mechanisms of the baculovirus
uggested the involvement of phospholipids in the entry
f baculovirus into both insect and mammalian cells.
his observation provides further insights into the effi-
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
A
4
v
a
344 TANI ET AL.cient transduction of mammalian cells and a better un-
derstanding of the virus–cell interaction of baculovirus at
the molecular level.
RESULTS
Construction of recombinant baculoviruses. To gener-
ate recombinant baculoviruses, the baculovirus transfer
vectors pAc64-CAluc, pAcVSVG-CAluc, pAcMHVS-CAluc,
and pAcGFP-CAluc were constructed by inserting
cDNAs encoding the gp64, VSVG, mouse hepatitis virus
S protein (MHVS), and green fluorescent protein (GFP)
genes under the polyhedrin promoter, respectively, and
the luciferase gene under the CAG promoter in the op-
posite orientation (Fig. 1A). The gp64, VSVG, MHVS, and
GFP proteins should be expressed by the polyhedrin
FIG. 1. (A) Construction of transfer vectors. Transfer vectors have the
luciferase gene under the control of the CAG promoter and the gp64,
VSVG, MHVS, or GFP gene under the control of the polyhedrin promoter
in the opposite orientation. The gp64, VSVG, MHVS, or GFP gene would
be activated by the polyhedrin promoter in insect cells, while the
luciferase gene under the CAG promoter would be activated in mam-
malian cells. Nucleotide numbers of baculovirus DNA are shown on the
vectors following the data reported previously by Ayres et al. (1994). (B)
Schematic representation of the recombinant baculoviruses Ac64-
CAluc, AcVSVG-CAluc, AcMHVS-CAluc, and AcGFP-CAluc.promoter at very high levels in insect cells but not in
mammalian cells. On the other hand, the luciferase gene
t
iunder the CAG promoter should be activated efficiently in
various mammalian cells but not at all or only poorly in
insect cells. To examine whether these recombinant
baculoviruses actually possess the gp64, VSVG, and
MHVS proteins as expected (Fig. 1B), we determined the
incorporation of the proteins into virions. Although ex-
pression of gp64 on the cell surface was detected in all
of the insect cells infected with the recombinant viruses,
the highest level of expression was observed in cells
infected with Ac64-CAluc (data not shown). The purified
virions were examined by Coomassie brilliant blue stain-
ing and Western blotting (Fig. 2). Incorporation of gp64 or
VSVG protein was easily detected in the purified virions
by the Coomassie staining gels. MHVS protein was not
readily evident in the Coomassie staining gels but was
clearly present as demonstrated by Western blot analy-
sis. Incorporation efficiencies of the gp64 in the purified
virions were determined by noting the intensities of gp64
made apparent by Western blotting after standardization
with the intensities of capsid protein of baculovirus de-
tected by Coomassie staining. Incorporation of gp64 into
Ac64-CAluc was 1.5–2 times higher than that of AcVSVG-
CAluc, AcMHVS-CAluc, and AcGFP-CAluc. These results
indicate that Ac64-CAluc has a larger amount of gp64
than do the other recombinant viruses, AcVSVG-CAluc,
AcMHVS-CAluc, or AcGFP-CAluc. Furthermore, the puri-
fied virions possessing 5 3 106 pfu to insect cells were
shown to have similar amounts of capsid proteins de-
tected by Coomassie staining gels. These results indi-
cate that the infectivities of the recombinant viruses to
insect cells are consistent with physical particles of the
recombinant viruses.
FIG. 2. Incorporation of gp64, VSVG, or MHVS protein in baculovirus
virions. The purified virions (5 3 106 pfu) of Ac64-CAluc (lane 1),
cVSVG-CAluc (lane 2), AcMHVS-CAluc (lane 3), or AcGFP-CAluc (lane
) were examined by Coomassie staining and Western blotting. Purified
irions were subjected to 10% SDS–PAGE and immunostained with
nti-gp64 antibody (top), anti-VSV antibody (middle), or anti-MHVS an-ibody (bottom). The gp64:capsid protein ratio was measured by NIH
mage on the bases of Coomassie staining and Western blotting data.
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345CELL-SURFACE MOLECULES IMPORTANT FOR BACULOVIRUS INFECTIONSusceptibility of various cell lines to the recombinant
baculoviruses. In previous studies, we demonstrated that
baculovirus vector can deliver and express foreign
genes into not only hepatocytes but also other mamma-
lian cells (Shoji et al., 1997). We then compared the
fficiency of reporter gene expression by Ac64-CAluc,
cVSVG-CAluc, AcMHVS-CAluc, and AcGFP-CAluc in
arious mammalian cell lines. Figure 3 indicates the
uciferase expression of various cell lines infected with
he recombinants at a m.o.i. of 50. All of the cell lines
nfected with AcVSVG-CAluc and AcMHVS-CAluc exhib-
ted 100- to 500-fold higher expression than did cell lines
nfected with AcGFP-CAluc. Cells infected with Ac64-
Aluc also showed 5- to 100-fold higher expression than
id cells infected with AcGFP-CAluc. Luciferase activity
ncreased in a dose-dependent manner in mammalian
ell lines infected with the recombinant viruses (data not
hown). These results indicate that recombinant baculo-
iruses possessing an increased amount of gp64 or
oreign envelope glycoproteins on the virions exhibit
igher gene transduction efficiency than does the control
aculovirus.
To confirm the roles of the gp64, VSVG, and MHVS
nvelope glycoproteins of the recombinant baculovi-
uses in facilitating the enhancement of infectivity, neu-
ralization by a specific antibody against gp64, VSV, and
HVS was examined in HepG2 cells (Fig. 4). The lucif-
rase expression by Ac64-CAluc was inhibited by anti-
p64 antibody (Fig. 4A). Although treatment with anti-
p64 antibody was more efficient at inhibiting luciferase
FIG. 3. Expression of luciferase in various mammalian cells infec
AcVSVG-CAluc, AcMHVS-CAluc, or AcGFP-CAluc at a m.o.i. of 50 and ha
under Materials and Methods. Values for relative light units (RLU) refe
n all cases. The results shown are the three independent assays withxpression by AcMHVS-CAluc than by AcVSVG-CAluc,
omplete inhibition of luciferase expression by AcVSVG-CAluc or AcMHVS-CAluc required treatment with both of
the anti-gp64 and anti-VSVG or anti-MHVS antibodies
(Figs. 4B and 4C). These results indicate that the en-
hancement of reporter gene transduction by the recom-
binant baculoviruses in mammalian cells relies on the
incorporation of the envelope glycoproteins gp64, VSVG,
or MHVS onto the virions.
Effect of enzyme and chemical modification of cells on
susceptibility of the recombinant baculoviruses. To ex-
amine the cell-surface determinants important for bacu-
lovirus infection, we compared the infectivities of Ac64-
CAluc, AcVSVG-CAluc, and AcMHVS-CAluc against
HepG2 cells treated with phospholipase C, Pronase, or
sodium periodate. The gp64 is the major protein respon-
sible for the initiation of the infection of baculoviruses,
and the efficiency of gene transduction by Ac64-CAluc
was higher than that of the control baculovirus AcGFP-
CAluc as described above. Therefore, Ac64-CAluc was
used for further experiments for characterization of the
infection mechanisms of baculoviruses. VSVG and
MHVS glycoproteins have been shown to recognize
phospholipids and carcinoembryonic antigen (CEA)-re-
lated proteins as receptors, respectively (Schlegel et al.,
1983; Williams et al., 1991). Therefore, AcVSVG-CAluc
and AcMHVS-CAluc were used as controls for the chem-
ical modification of HepG2 cells. Phospholipase C and
Pronase are known to digest phospholipids and proteins,
respectively. Sodium periodate removes carbohydrates
chains from glycoproteins. When cells were treated with
phospholipase C, the infectivity of Ac64-CAluc and
h recombinant baculoviruses. Cells were infected with Ac64-CAluc,
d at 24 h after infection. Luciferase activity was measured as described
racts from 105 cells. The value for mock-infected cells was subtracted
rror bars representing SD.ted wit
rvesteAcVSVG-CAluc was markedly reduced in a dose-depen-
dent manner, while AcMHVS-CAluc was shown to be
od with
ys with
346 TANI ET AL.more resistant to the treatment than were Ac64-CAluc
and AcVSVG-CAluc (Fig. 5A). Treatment with Pronase or
sodium periodate resulted in no reduction in luciferase
expression of the cells infected with the recombinant
baculoviruses. Although treatment of cells with Pronase
at concentration of 5 mg/ml or more was sufficient to
abolish the susceptibility of cells to pseudotype VSV
possessing Ebola virus glycoprotein (Takada et al., 1997)
r HCV envelope proteins (Matsuura et al., submitted),
the infectivities of AcMHVS-CAluc were not changed
with Pronase treatment. This might be explained by the
fact that AcMHVS-CAluc can utilize gp64 during the in-
fection of cells treated with Pronase. As shown in Fig. 4,
anti-gp64 antibody showed higher neutralization activity
than did anti-MHVS antibody in the infection with AcM-
HVS-CAluc, in contrast to the neutralization of infection
with AcVSVG-CAluc in which anti-VSVG antibody showed
higher activity than did anti-gp64 antibody.
To examine whether the treatment of insect cells with
these reagents also affects the infectivity of baculovi-
ruses, plaque assay was carried out in Sf9 cells treated
with various chemicals (Fig. 5B). The reduction of plaque
number of Ac64-CAluc was observed in cells treated
with phospholipase C but not in those treated with Pro-
nase or sodium periodate. Similar results were obtained
by other recombinant baculoviruses (data not shown).
Cytotoxic effect by the chemical treatments of mamma-
lian and insect cells was determined by trypan blue
staining. No serious cytotoxicity was observed after
treatment with the chemicals on the range of a concen-
tration used in these experiments (Figs. 5A and 5B).
These results suggest that phospholipids on the cell
FIG. 4. Neutralization of luciferase expression of the recombinant
recombinants were incubated with indicated antibodies, and lucifera
Ac64-CAluc was treated with anti-gp64 antibody (open circles). (B) A
antibody (closed circles), or anti-gp64 antibody and anti-VSVG antibody
circles), anti-MHVS antibody (closed circles), or anti-gp64 antibody and
determined as the percentage of luciferase expression in cells infecte
viruses. The results shown are the average of three independent assasurface play an important role in the infection of mam-
malian and insect cells by baculoviruses.Effects of purified lipids on the infectivity of baculovi-
ruses. To obtain additional information on the cell sur-
face determinants important for baculovirus infection, we
examined the effect of various purified lipids on the
infectivity of Ac64-CAluc. AcVSVG-CAluc was utilized as
a control for the experiments because the receptor of
VSV was suggested to be some phospholipids, mainly
plasma membrane PS (Schlegel et al., 1983). The purified
lipids preparations (10 mM) of PA, PI, PS, PE, PG, PC, and
SP prepared in PBS containing 50 mM n-octyl-b-D-gluco-
pyranoside were incubated with the viruses, and the
effect on luciferase expression in HepG2 cells was de-
termined (Fig. 6). To examine the effect of the lipids’
solvent, the viruses were incubated with 50 mM n-octyl-
b-D-glucopyranoside without lipid. PA (90%), PI (60%), and
PS (43%) exhibited the most potent inhibiting activities on
the infection of Ac64-CAluc. On the other hand, potent
inhibiting activities on the infection of AcVSVG-CAluc
were shown by the treatments with PA (80%), PG (67%),
PE (50%), and PS (45%). The effects of PA and PI on the
inhibition of infectivity of Ac64-CAluc were also exhibited
in a dose-dependent manner (data not shown). These
results indicate that phospholipids PA and PI might be
involved in the initiation of baculovirus infection into
mammalian cells.
Infectivities of the recombinant baculoviruses on mu-
tant CHO cell lines. To confirm the effects of membrane
phospholipids on the infection of baculoviruses, we exam-
ined the infectivity of Ac64-CAluc and AcVSVG-CAluc to the
mutant CHO cell lines with altered membrane phospholipid
composition (Fig. 7). In mutant 51.13, which is deficient in PI
synthesis in growth medium lacking myo-inositol, we ob-
viruses by anti-gp64 and/or anti-VSVG or MHVS antibodies. These
ression was examined in HepG2 cells after 24 h of incubation. (A)
CAluc was treated with anti-gp64 antibody (open circles), anti-VSVG
quares). (C) AcMHVS-CAluc was treated with anti-gp64 antibody (open
HVS antibody (open squares). The relative luciferase expression was
the antibody-treated viruses relative to those infected with nontreated
the error bars representing SD.baculo
se exp
cVSVG-
(open s
anti-Mserved a 62% reduction of luciferase expression by Ac64-
CAluc in the PI-depleted condition, whereas only a 23%
v
w 106 pf
senting
347CELL-SURFACE MOLECULES IMPORTANT FOR BACULOVIRUS INFECTIONreduction was detected when PI-depleted cells were in-
fected with AcVSVG-CAluc in the same condition. In mutant
PSA-3, which is deficient in PS synthesis and requires
exogenous PS for growth, we observed a 55% reduction of
luciferase by AcVSVG-CAluc in the PS-depleted condition,
whereas a 30% reduction in expression was detected by
Ac64-CAluc. On the other hand, mutant CT58, which re-
duces PC synthesis at 40°C, showed no difference in sus-
FIG. 5. Effect of chemical modification of HepG2 and insect cells on
or AcMHVS-CAluc. (A) HepG2 cells were preincubated with various con
of Ac64-CAluc, AcVSVG-CAluc, or AcMHVS-CAluc was examined by the
(RLU) refer to extracts from 105 cells. The results shown are the ave
iabilities were determined by trypan blue staining, and results are repr
ith the indicated concentration of the reagents, and serially diluted 5 3
are the average of three independent assays with the error bars repreceptibility to Ac64-CAluc and AcVSVG-CAluc. The control
cell line, CHO K1, exhibited no reduction in reporter geneexpression irrespective of the culture conditions. These
results are consistent with the data for inhibition obtained
by the purified lipids shown in Fig. 6 and suggest that PI on
the cell surface might play an important role in the infection
with baculoviruses.
DISCUSSION
ceptibility of the recombinant baculovirus Ac64-CAluc, AcVSVG-CAluc,
tions of phospholipase C, Pronase, or sodium periodate. Susceptibility
sion of luciferase after 24 h of incubation. Values for relative light units
three independent assays with the error bars representing SD. Cell
tive of three independent experiments. (B) Sf9 cells were preincubated
u/ml of Ac64-CAluc was plaque titrated on the cells. The results shown
SD.the sus
centra
expres
rage of
esentaThe infection of viruses into host cells is initiated by
the binding of the virus to the cell surface and the entry
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348 TANI ET AL.of the virus genome into cells. Binding is mediated by the
viral binding proteins, which recognize a specific recep-
tor molecule on the cell surface. Enveloped viruses use
proteins embedded in the viral membrane for specific
recognition of receptors such as protein molecules, car-
bohydrates, and lipids (Lentz, 1990). Specific receptor
FIG. 6. Inhibition of luciferase expression of the recombinant bacu-
lovirus by purified lipids. Ac64-CAluc or AcVSVG-CAluc was incubated
with the concentration of 10 mM of purified lipids, and luciferase activity
as examined in HepG2 cells after 24 h of incubation. As a control, the
irus was treated with the same concentration of n-octyl-b-D-glucopy-
anoside solution including no lipids (non). PA, phosphatidic acid; PI,
hosphatidylinositol; PS, phosphatidylserine; PG, phosphatidylglycerol;
C, phosphatidylcholine; PE, phosphatidylethanolamine; SP, sphingo-
yelin. The results shown are the average of three independent assays
ith the error bars representing SD.
FIG. 7. Infectivities of the recombinant baculoviruses on mutant CHO
cultured as described under Materials and Methods, and then these cells were
was examined after 24 h of incubation.molecules have been identified, including a CD4 mole-
cule (Dalgleish et al., 1984; Klatzmann et al., 1984) and
hemokine receptor family as a co-receptor (Littman,
998) for human immunodeficiency virus, sialyloligosac-
harides for influenza virus (Paulson et al., 1979), and
hosphatidylserine for VSV (Schlegel et al., 1983).
For a budded baculovirus, it has been shown that the
ajor envelope fusion protein gp64 determines the viral
eceptor preference in the inhibition studies with an
nti-gp64 monoclonal antibody and thus defines the viral
ost range or the efficiency of infectivity to the host
Hohmann and Faulkner, 1983; Volkman and Goldsmith,
985). The biological characteristics of gp64 have been
tudied in detail in insect cells, and it has been found
hat gp64 is necessary and sufficient for low-pH-trig-
ered membrane fusion activity (Blissard and Wenz,
992; Jarvis and Garcia, 1994; Chernomordik et al., 1995;
onsma and Blissard, 1995; Oomens et al., 1995; Mark-
vic et al., 1998; Plonsky et al., 1999). In truncation and
substitution studies, gp64 was shown to be essential for
the propagation of the budded virus infection through
cell-to-cell transmission (Monsma et al., 1996) and im-
ortant for efficient virion budding (Oomens and Blissard,
999). Studies using electron microscopy and some in-
ibitors have suggested that for infection of mammalian
ells with the budded baculovirus, viruses were internal-
zed by an endosomal pathway (Volkman et al., 1983;
Carbonell et al., 1985; Carbonell and Miller, 1987; Hof-
ann et al., 1995; Boyce and Bucher, 1996; Condreay et
l., 1999). However, the precise mechanisms for the
inding and entry of baculoviruses into mammalian cells
nd insect cells are not yet known.
es. The mutant CHO cell lines 51.13 (A), PSA-3 (B), and CT58 (C) werecell lin
infected with Ac64-CAluc or AcVSVG-CAluc and luciferase expression
349CELL-SURFACE MOLECULES IMPORTANT FOR BACULOVIRUS INFECTIONRecent studies suggest the possibility of using bacu-
loviruses as vectors for gene therapy; therefore, identifi-
cation of the host cellular receptor on mammalian cells
will be important for further understanding of the host
specificity of the budded baculovirus. To examine the
role of the gp64 protein in infection of mammalian cells
by baculovirus, we have constructed a recombinant bac-
ulovirus Ac64-CAluc possessing an extra gp64 gene
under the control of the polyhedrin promoter. Ac64-CAluc
was shown to have a 1.5 times higher amount of gp64
protein on the virion and to exhibit higher reporter gene
expression in a broader range of mammalian cells than
that of the control baculovirus AcGFP-CAluc. These re-
sults, in conjunction with the inhibition of expression by
the specific antibody against gp64 protein, indicate that
baculovirus gp64 envelope fusion protein recognizes
some common molecules as a receptor on the surface of
various mammalian cells. In this study, we utilized the
very late polyhedrin promoter for expression of the gp64
or other foreign viral proteins. Therefore viruses budded
in the early stage of infection may not be able to incor-
porate the proteins into virions. Application of the imme-
diate early promoter for expression of the proteins might
improve the efficiency of incorporation into the budded
viruses.
Enzyme treatments of the host cells are commonly
used to characterize the specific cellular receptors for
many viruses. In baculoviruses, treatment of insect cells
with proteases was shown to decrease virus binding
(Wickham et al., 1992; Wang et al., 1997). In contrast, the
infectivity of Ac64-CAluc was drastically decreased by
the treatment of HepG2 cells with phospholipase C but
not with Pronase or sodium periodate in this study. This
might reflect the difference in assay systems or be due to
the difference in enzymes or concentration used for
treatment. In this study, we used pseudotype baculovi-
ruses possessing VSVG or MHVS proteins on the virion
as controls. VSVG and MHVS proteins were reported to
recognize phospholipids and CEA-related proteins as
receptors, respectively (Schlegel et al., 1983; Williams et
al., 1991). Although the expression level of CEA-related
proteins on a mammalian cell line was not examined,
one of the MHV strains, JHM, which we used, was infec-
tious to HepG2 cells (Koetters et al., 1999). Treatments of
cells with a higher concentration of the chemicals
caused excessive cell damage; however, the phospho-
lipase C treatment used in this study did not cause any
cell damage and AcMHVS-CAluc continued to be infec-
tious to the treated cells. AcVSVG-CAluc was also shown
to be sensitive to the treatment with phospholipase C as
Ac64-CAluc. These enzyme and chemical modification
analyses suggest that baculoviruses utilize phospholip-
ids on the cell surface in the process of infection. Fur-
thermore, the inhibition of viral infection by pretreatment
with purified PA or PI and susceptibility of the viruses to
the mutant CHO cell lines deficient in phospholipid syn-thesis suggest that these phospholipids play important
roles in binding or penetration of baculoviruses into
insect and mammalian cells.
The involvement of phospholipids in the binding or
entry process of enveloped viruses has been reported.
Semliki forest virus requires sphingolipids on the target
membrane for fusion activity (Nieva et al., 1994). The
binding and penetration of Ebola virus are activated by
the presence of PI (Ruiz-Arguello et al., 1998). VSV pref-
erentially binds to PS, PE, and PA (Schlegel et al., 1983)
and also binds to PI, diphosphatidylglycerol and ganglio-
sides, suggesting that these substances interact electro-
statically because of their common negative electric
charges (Mastromarino et al., 1987). As for baculovirus,
Chernomordik et al. indicated that biological membrane
fusion mediated by the gp64 was modulated by some
specific changes in the lipid composition of the cell
membrane (Chernomordik et al., 1995). Although PA and
PI inhibited the viral infection of HepG2 cells in this
study, the major membrane phospholipids of HepG2
cells and insect cells were composed mainly by PC and
PE (Koumanov et al., 1990; Marheineke et al., 1998). Both
PA and PI are acidic lipids, which suggested ionic inter-
actions between the baculovirus and the lipids. However,
the infection of mammalian cells with baculovirus was
not inhibited by preincubation with acidic glycosamino-
glycans such as heparin or heparan sulfate (data not
shown), suggesting that the inhibition of baculovirus in-
fection by the purified lipids is not due to the ionic
interactions. Further studies are needed to clarify the
mechanisms of baculovirus and phospholipid interac-
tion.
In previous studies, baculovirus AcNPV efficiently en-
tered human hepatocytes and other mammalian cell
lines (Hofmann et al., 1995; Boyce and Bucher, 1996;
Shoji et al., 1997). Recently, it has been reported that a
pseudotype baculovirus incorporating the VSVG protein
extended the host range and increased the transduction
efficiency in mammalian cells (Barsoum et al., 1997). The
pseudotype retroviruses possessing VSVG protein have
been shown to exhibit a broader host range and a higher
transduction efficiency than that of the original retrovi-
ruses (Emi et al., 1991; Burns et al., 1993). This is be-
cause VSV was shown to binds to PS as a cellular
receptor that is widely distributed on the plasma mem-
brane and exhibits a broader host range. In the applica-
tion of in vivo studies of baculoviruses for gene therapy,
recent studies suggest that baculoviruses could not be
utilized in vivo due to inactivation of the virus by the
serum complement systems (Sandig et al., 1996; Hof-
mann and Strauss, 1998). In the case of retroviruses,
pseudotype viruses with VSV-G were shown to be more
resistant to the complement than were the normal retro-
viruses (Ory et al., 1996). Although Ac64-CAluc and
AcVSVG-CAluc were shown to be more resistant to the
human and animal complements in vitro than was the
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350 TANI ET AL.control baculovirus, we have not succeeded in producing
the expression of reporter gene in vivo (data not shown).
Further studies in vivo for efficient transduction in ani-
mals are needed.
In this study, we were able to demonstrate that the
infectivity of a baculovirus into mammalian cells can be
enhanced by the incorporation of an extra amount of its
own envelope protein, gp64. Thus, we have provided a
direction for future research on cellular receptors and
possible cofactors that affect baculovirus entry into
mammalian or insect cells. Furthermore, if it was possi-
ble to complement the gp64 proteins with other foreign
proteins, development of the targeting vectors for gene
therapy and analyses of functions of other viral envelope
proteins might become possible.
MATERIALS AND METHODS
Construction of plasmids. Recombinant baculoviruses
were constructed by use of the transfer vectors pAc-
Surf-2, which has the gp64 gene under the polyhedrin
promoter (provided by Dr. I. M. Jones) (Boublik et al.,
1995), and pAcYM1 (Matsuura et al., 1987). pAcVSV-G
was constructed by excision of the cDNA of VSV-G from
pCA-VSVG (Takikawa et al., 2000) by digestion with
EcoRI, was filled in with Klenow enzyme, and was cloned
into the BamHI site of pAcYM1 after ligation of the BamHI
linker. pAcMHVS was constructed by excision of the
cDNA of MHVS from pTargetJHM-cl-2S (provided by Dr. F.
Taguchi) (Taguchi et al., 1992) by digestion with XhoI and
SmaI, was filled in with Klenow enzyme, and was cloned
into the SmaI site of pAcYM1. pAcGFP was constructed
by excision of the cDNA of GFP from pKS588 (provided
by Dr. K. Sakai) by digestion with BamHI and was cloned
into the BamHI site of pAcYM1. To express foreign genes
in mammalian cells, the Photinus pyralis luciferase gene
was introduced into the baculovirus vectors under the
control of the CAG promoter. To construct the transfer
vectors pAc64-CAG, pAcVSVG-CAG, pAcMHVS-CAG,
and pAcGFP-CAG, the CAG cassette was excised from
pCAGGS (Niwa et al., 1991) by use of SalI and BamHI,
was filled in with Klenow enzyme, and was inserted into
the EcoRV site of pAcSurf-2, pAcVSVG, pAcMHVS, and
pAcGFP in an opposite direction to the polyhedrin pro-
moter. To generate pAc64-CAluc, pAcVSVG-CAluc, pAc-
MHVS-CAluc, and pAcGFP-CAluc, the luciferase gene
was excised from a plasmid PG-CS (Toyo Ink Co. Ltd.,
Tokyo, Japan) with XhoI and XbaI, was filled in with
Klenow enzyme, and was cloned into the BglII site of
pAc64-CAG, pAcVSVG-CAG, pAcMHVS-CAG, and
pAcGFP-CAG plasmid after addition of the BclI linker.
Cells and viruses. AcNPV and recombinant baculovi-
uses were grown and assayed in Spodoptera frugiperda
Sf) 9 cells in TC100 medium (Gibco Laboratories, Grand
sland, NY) supplemented with 0.26% Bactotryptose
roth (Difco, Detroit, MI), 100 mg of kanamycin per ml and10% fetal bovine serum (FBS). The recombinant baculo-
viruses Ac64-CAluc, AcVSVG-CAluc, AcMHVS-CAluc,
and AcGFP-CAluc were generated by homologous re-
combination of baculovirus DNA with pAc64-CAluc,
pAcVSVG-CAluc, pAcMHVS-CAluc, and pAcGFP-CAluc,
respectively. These recombinants were purified as fol-
lows; culture supernatants were harvested at 3 days
after infection, and cell debris was removed by centrifu-
gation at 6000 g for 15 min at 4°C. Virus was pelleted
own by ultracentrifugation at 25,000 rpm in an SW28
otor (Beckman, Palo Alto, CA) for 60 min and was re-
uspended in phosphate-buffered saline (PBS), was
oaded on 10–60% (w/v) sucrose gradients, and was
ltracentrifuged at 25,000 rpm in an SW41E rotor (Beck-
an) for 60 min. The virus band was collected and
esuspended in PBS and was ultracentrifuged at 25,000
pm in the SW41E rotor for 60 min. The virus pellet was
esuspended in PBS, and infectious titers were deter-
ined by plaque assay (Shoji et al., 1997; Matsuura et al.,
987).
Various mammalian cell lines were used to examine
ene expression by the recombinant baculoviruses, in-
luding human cell lines (HepG2, Huh7, FLC4, HeLa, and
93T), monkey kidney cell lines (CV-1), a porcine kidney
ell line (CPK), hamster cell lines (BHK and CHO), a
uffalo rat liver cell line (BRL3A), and a normal mouse
iver cell line (NMuLi). These cells were grown in Dul-
ecco’s modified Eagle’s medium (DMEM) (Gibco Labo-
atories) containing 2 mM L-glutamine, penicillin (50 IU/
ml), streptomycin (50 mg/ml), and 10% FBS. All of the
cells, except FLC4, 293T, and CPK cells, were purchased
from the Dainippon Pharmaceutical Co., Ltd. (Osaka,
Japan). FLC4, 293T and CPK cells were provided by Drs.
S. Nagamori, Y. Kitamura, and A. Fukusho, respectively.
Mutant CHO cell lines with altered membrane phospho-
lipid composition, 51.13 (Esko and Raetz, 1980a) and
CT58 (Esko and Raetz, 1980b), were provided by Dr. J. D.
Esko; isolation of PSA-3 was described previously (Kuge
et al., 1986).
Expression of viral envelope protein. Expression of
gp64, VSVG, MHVS, or GFP protein in insect cells in-
fected with Ac64-CAluc, AcVSVG-CAluc, AcMHVS-CAluc,
or AcGFP-CAluc was analyzed by Western blotting, im-
munofluorescence analysis, and fluorescence micro-
scopic observation. The purified viruses were separated
by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS–PAGE), and proteins were blotted to a
polyvinylidene difluoride membrane (Millipore, Tokyo, Ja-
pan). Anti-gp64 mouse monoclonal antibody, anti-VSV
rabbit polyclonal antibody, and anti-MHVS mouse mono-
clonal antibody were used as the first antibody. Each
protein was detected by using the alkaline phosphatase
assay methods as described previously (Ruggieri et al.,
1997). Immunofluorescence analysis was also carried
out as described previously (Yap et al., 1997) except that
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sion of GFP was examined by fluorescence microscopy.
Luciferase assay. Various mammalian cell lines were
infected with the recombinant baculoviruses at m.o.i. of
50 and incubated for 24 h at 37°C. Luciferase activity
was determined by the Pica Gene luciferase assay kit
(Toyo Ink Co. Ltd.) according to the manufacturer’s in-
structions. Cells (1 3 105) were lysed with 100 ml of the
cell lysis buffer LUC/PGC-50 (Toyo Ink Co. Ltd.). Twenty
microliters of cleared cell lysate was incubated with 100
ml of a reaction mixture containing 137 mM NaCl, 2.7 mM
KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, 20 mM Tricine,
.07 mM (MgCO3)4Mg(OH)25H2O, 2.67 mM MgSO4, 0.1
mM EDTA, 33.3 mM DTT, 270 mM Coenzyme A, 470 mM
luciferin, and 530 mM ATP. Relative light units (RLU) were
measured by the use of a luminometer (Berthold, Wild-
bad, Germany). Bioluminescent reaction was catalyzed
by adding 20 ml of each standard to 100 ml of reaction
mixture.
Reagents. Phospholipase C (Bacillus cereus Grade I)
was obtained from Boehringer Mannheim (Mannheim,
Germany). Pronase, sodium periodate (NaIO4), phospha-
tidic acid (PA), phosphatidylinositol (PI), phosphatidylser-
ine (PS), phosphatidylcholine (PC), phosphatidylethano-
lamine (PE), phosphatidylglycerol (PG), and sphingomy-
elin (SP) were obtained from Sigma (St. Louis, MO).
Anti-VSV polyclonal antibody was purchased from Lee
BioMolecular Research Laboratories, Inc (San Diego,
CA), and anti-VSVG monoclonal antibody was provided
by Dr. M. A. Whitt. Anti-gp64 monoclonal antibodies,
B12D5 and AcV1, were provided by Drs. L. E. Volkman
and P. Faulkner, respectively. Anti-MHVS monoclonal an-
tibodies, #3 (Kubo et al., 1993) and 10G (Routledge et al.,
991), were provided by Dr. F. Taguchi.
Neutralization test. To examine whether the antibody
gainst gp64, VSVG, or MHVS would specifically block
he expression by the recombinant baculoviruses, virus
olution containing 106 pfu of infectious virus in 50 ml of
serum-free DMEM was incubated with various dilutions
of the antibodies at 37°C for 60 min. The mixtures were
then inoculated into HepG2 cells and were washed twice
with medium after absorption for 60 min. After 24 h of
incubation at 37°C, neutralization by the antibodies was
determined by the reduction of luciferase expression.
Chemical modification of cells. HepG2 cells (1 3 105)
repared in a 48-well plate were washed with serum-free
MEM three times and were incubated with 250 ml of the
serum-free DMEM containing various concentrations of
phospholipase C, Pronase, or sodium periodate at 37°C
for 30, 20, and 60 min, respectively. After washing three
times with DMEM containing 10% FBS, the cells were
infected with Ac64-CAluc, AcVSVG-CAluc, or AcMHVS-
CAluc at m.o.i. of 50. After absorption for 60 min at 37°C,
the cells were washed three times with DMEM contain-
ing 10% FBS and were incubated for 24 h at 37°C. Then
the cells were harvested, and luciferase activity wasdetermined. Sf9 cells (1 3 106) prepared in a 35-mm dish
were treated with the serum-free TC100 containing var-
ious concentrations of these chemicals at 26°C for the
same periods as the experiments with HepG2 cells.
Reduction of infectivity of Ac64-CAluc (100 pfu) was de-
termined by plaque assay. Viabilities of HepG2 and Sf9
cells treated with the reagents were determined by stain-
ing with trypan blue.
Effects of pretreatment of the recombinant baculovi-
ruses with purified lipids on expression. Chloroform so-
lutions of the purified lipids were dried up and solubilized
in PBS containing 50 mM n-octyl-b-D-glucopyranoside
(Sigma) at a concentration of 10 mg/ml. The lipid solu-
tions were stored at 4°C and were diluted before use.
Ac64-CAluc (2 3 106 pfu) or AcVSVG-CAluc (2 3 106 pfu)
nd various concentrations of the purified lipid solutions
ere incubated in 50 ml of PBS at room temperature for
90 min. The mixtures were inoculated into HepG2 cells
(1 3 105) in a 48-well plate and were incubated at 37°C
for 1 h. After incubation, the solutions were completely
removed, and the cells were washed twice and were
incubated with 250 ml of DMEM containing 10% FBS. The
cells were harvested after 24 h of incubation at 37°C,
and luciferase activity was determined.
Infectivities of the recombinant baculoviruses on the
mutant CHO cell lines. Mutant 51.13, a myo-inositol auxo-
troph, reduces phosphatidylinositol synthesis under the
condition of myo-inositol starvation (Esko and Raetz,
1980a). Mutant PSA-3, a phosphatidylserine auxotroph,
reduces phosphatidylserine content under the condition
of phosphatidylserine starvation (Kuge et al., 1986). Mu-
tant CT58 is a temperature-sensitive mutant that reduces
phosphatidylcholine synthesis when cultured at a non-
permissive temperature, 40°C (Esko and Raetz, 1980b).
These mutant cell lines and a parent cell line, CHO-K1,
were cultured in a 48-well plate for 48 h under the
permissive and non-permissive conditions as described
previously (Esko and Raetz, 1980a,b; Kuge et al., 1986).
After 48 h of incubation, cells were washed with DMEM
containing 10% FBS and were inoculated with Ac64-
CAluc or AcVSVG-CAluc. Cells were washed twice with
DMEM containing 10% FBS after 60 min absorption, and
luciferase activity was determined after 24 h of incuba-
tion under the competent conditions for the phospholipid
syntheses.
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